OWA
GILD icon

Outlook Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Outlook Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,113
Closed -$429K – 260
2024
Q3 		$429K Buy
5,113
+247
+5% +$18.8K 0.12% 146
2024
Q2 		$334K Buy
+4,866
New +$325K 0.1% 197
2020
Q1 		– Sell
-3,815
Closed -$248K – 166
2019
Q4 		$248K Sell
3,815
-3,271
-46% -$213K 0.14% 129
2019
Q3 		$449K Buy
+7,086
New +$463K 0.27% 81

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Outlook Wealth Advisors's GILD Position: Q4 2024 in Review

Outlook Wealth Advisors sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 5,113 shares — an estimated $429K sold.

Outlook Wealth Advisors first reported a position in GILD in Q3 2019 and held it in 4 quarters. The position peaked at $449K in Q3 2019. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Outlook Wealth Advisors reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • Outlook Wealth Advisors sold 5,113 Gilead Sciences shares in Q4 2024, an estimated $429K.
  • Outlook Wealth Advisors first reported a position in Gilead Sciences in Q3 2019 and held it in 4 quarters.
  • Outlook Wealth Advisors's Gilead Sciences position peaked at $449K in Q3 2019.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Outlook Wealth Advisors's 13F filing for Q4 2024, filed 14 Jan 2025.